Pharmaceuticals

Cell Sheet-Based Gene Therapy Market Report 2026: Strategic Insights and Revenue Outlook

March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cell sheet-based gene therapy market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Cell Sheet-Based Gene Therapy Market?

The cell sheet-based gene therapy market has seen significant expansion in recent years. This market is projected to expand from $0.68 billion in 2025 to $0.78 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.4%. Historically, this expansion has been linked to several factors, including increasing progress in tissue engineering research, the early embrace of regenerative medicine techniques, an uptick in cell-based therapeutic studies, enhancements in gene delivery technologies, and the broader development of translational research initiatives.

The cell sheet-based gene therapy market is anticipated to experience significant expansion over the coming years. Projections indicate it will reach $1.34 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.6%. This projected growth is driven by several factors, including a heightened demand for localized regenerative treatments, an increase in clinical trials involving gene-modified cell therapies, the broadening of applications in oncology and cardiology, an uptick in investments in sophisticated tissue engineering, and a sharper focus on precision regenerative medicine. Key trends anticipated during this period encompass the development of multilayered and co-culture cell sheet technologies, a stronger emphasis on localized gene expression therapies, the increasing incorporation of regenerative medicine strategies, greater utilization of stem-cell derived cell sheets, and an intensified focus on tissue integration and long-term viability.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33058&type=smp

Which Drivers Are Supporting The Rise Of The Cell Sheet-Based Gene Therapy Market?

An increase in chronic and degenerative diseases is anticipated to fuel expansion within the cell sheet-based gene therapy market. These long-term conditions encompass ailments such as cardiovascular disorders, neurodegenerative diseases, diabetes, and genetic disorders. They gradually impair tissues and organs, necessitating ongoing treatment. The frequency of these conditions is climbing, driven by an aging global populace and longer life expectancies in both developed and developing nations. Cell sheet-based gene therapy offers regenerative treatment solutions for chronic and degenerative diseases, facilitating localized tissue regeneration and consistent gene delivery via stacked living cell constructs, thereby enhancing tissue integration and sustained therapeutic results. As an illustration, in April 2025, the International Diabetes Federation (IDF), a non-profit organization based in Belgium, reported that 589 million individuals globally had diabetes in 2024, a number expected to increase to 853 million by 2050. Consequently, the growing occurrence of chronic and degenerative diseases is propelling the expansion of the cell sheet-based gene therapy market.

What Leading Segments Are Studied In The Cell Sheet-Based Gene Therapy Market?

The cell sheet-based gene therapy market covered in this report is segmented –

1) By Cell-Sheet Type: Monolayer Cell-Sheet Type; Co-Culture Cell-Sheet Type; Multilayered Cell-Sheet Type; Other Cell-Sheet Types

2) By Technology Type: Cell Sheet-Based Engineering Techniques; Gene Delivery Methods

3) By Source Type: Autologous; Allogenic; Stem-Cell Derived

4) By Application: Oncology; Ophthalmology; Genetic Disorders; Cardiology; Other Applications

5) By End-User: Hospitals And Clinics; Research And Academic Institutions; Biotech And Pharma Companies; Other End-Users

Subsegments:

1) By Monolayer Cell-Sheet Type: Cardiomyocyte Sheets; Epithelial Cell Sheets; Mesenchymal Stem Cell Sheets; Other Monolayer Cell Sheets

2) By Co-Culture Cell-Sheet Type: Fibroblast + Stem Cell Sheets; Endothelial + Smooth Muscle Cell Sheets; Other Co-Culture Combinations

3) By Multilayered Cell-Sheet Type: Triple-Layered Sheets; Double-Layered Sheets; Other Multilayered Configurations

4) By Other Cell-Sheet Types: Genetically Modified Cell Sheets; Hybrid Cell Sheets; Other Novel Or Experimental Sheets

Which Innovation Trends Are Advancing Developments Within The Cell Sheet-Based Gene Therapy Market?

Leading companies in the cell sheet-based gene therapy market are concentrating on developing advanced solutions, such as autologous gene-corrected cell sheet products, to improve regenerative medicine outcomes, enhance treatment precision, and achieve long-term tissue repair. This is accomplished by integrating engineered cells with scaffold-free sheet constructs for targeted gene delivery and effective wound healing. Autologous gene-corrected cell sheet products are therapies where a patient’s own cells are genetically altered ex vivo, grown into sheet structures that maintain crucial cell-to-cell interactions and extracellular matrix integrity, and then directly applied to damaged tissues to encourage functional integration and durable therapeutic effects. For instance, in April 2025, Abeona Therapeutics Inc., a US-based biopharmaceutical company, secured approval from the US federal agency Food and Drug Administration (FDA) for zevaskyn (prademagene zamikeracel). This product is specifically designed to treat wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). Zevaskyn delivers the functional COL7A1 gene through genetically corrected cell sheets, resulting in clinically significant wound healing and pain reduction with just a single application, and supports sustained type VII collagen expression at wound sites—marking it as a breakthrough regenerative therapy and a blueprint for future innovations in cell sheet-based gene therapy.

Which Key Players Are Driving Competition In The Cell Sheet-Based Gene Therapy Market?

Major companies operating in the cell sheet-based gene therapy market are Hitachi Ltd., Thermo Fisher Scientific, Fujifilm Cellular Dynamics Inc. (FCDI) (FUJIFILM Holdings Corporation), Lonza Group AG, teijin regenet co. ltd., Terumo Corporation, Nikon CeLL innovation Co. Ltd., Rohto Pharmaceutical Co. Ltd., BioBridge Global, AGC Biologics, Shibuya Corporation (Shibuya Kogyo Co. Ltd.), National Resilience Inc., Takara Bio Inc., Japan Tissue Engineering Co. Ltd. (J-TEC), Medipost Co. Ltd., Cell Therapies Pty Ltd, CellSeed Inc., SCTbio, Abeona Therapeutics Inc., Foundation ENEA Tech, Cyto-Facto Inc., ENCELL Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cell-sheet-based-gene-therapy-market-report

Which Region Is Projected To Lead The Cell Sheet-Based Gene Therapy Market During The Forecast Period?

North America was the largest region in the cell sheet based gene therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell sheet-based gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cell Sheet-Based Gene Therapy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33058&type=smp

Browse Through More Reports Similar to the Global Cell Sheet-Based Gene Therapy Market 2026, By The Business Research Company

Cell And Gene Therapy Clinical Trial Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report

Cell And Gene Therapy Manufacturing Services Market 2026

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-manufacturing-services-market

Cell And Gene Therapy Supply Chain Or Logistics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795